“The Enterprise coped with the plans approved by the Program of Activities,” said Yu.A. Bozhkov, the chief accountant of FSUE Moscow Endocrine Plant. - Sales revenue for the first half of 2019 amounted to 1825 million roubles, which corresponds to the planned indicators.
Received net assets were 7 times higher than the authorized capital, the balance sheet currency increased by 15834 million roubles. In June, deductions from net profit were made to the federal budget in the amount of 70 million roubles, 27 million roubles were sent to the innovative development of the enterprise. According to the results of the half-year period the Enterprise put into operation fixed assets used in production activities in the amount of 150 million roubles, the net assets for the half-year period increased by 28 million roubles and reached 3607 million roubles.
The Enterprise has a high level of financial stability, provides liquidity for all current and subsequent liabilities, has sufficient working capital funds to repay short-term liabilities.
The Enterprise follows the path of innovative development, quality improvement and competitiveness of products, explores new areas of activity, attracting for this purpose budget investment funds, bank loans, using its own earned funds.
Comment type is not specified in the component properties.